Novartis AG Share Price

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange 16:31:22 12/04/2024 BST 5-day change 1st Jan Change
86.1 CHF +0.55% Intraday chart for Novartis AG +0.05% +1.45%

Financials

Sales 2024 * 48.09B 43.95B 3,863B Sales 2025 * 50B 45.69B 4,016B Capitalization 207B 189B 16,613B
Net income 2024 * 10.4B 9.5B 835B Net income 2025 * 11.38B 10.4B 914B EV / Sales 2024 * 4.55 x
Net Debt 2024 * 11.94B 10.91B 959B Net Debt 2025 * 9.62B 8.79B 773B EV / Sales 2025 * 4.33 x
P/E ratio 2024 *
18.4 x
P/E ratio 2025 *
16.4 x
Employees 76,057
Yield 2024 *
3.82%
Yield 2025 *
3.99%
Free-Float 81.95%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.55%
1 week+0.05%
Current month-1.45%
1 month-1.18%
3 months-5.83%
6 months-1.62%
Current year+1.45%
More quotes
1 week
85.37
Extreme 85.37
87.22
1 month
84.79
Extreme 84.79
88.83
Current year
84.79
Extreme 84.79
94.52
1 year
83.00
Extreme 83
94.77
3 years
72.84
Extreme 72.84
94.77
5 years
65.09
Extreme 65.09
96.38
10 years
65.09
Extreme 65.09
103.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 31/12/04
Director of Finance/CFO 59 31/12/02
Chief Tech/Sci/R&D Officer 62 15/05/22
Members of the board TitleAgeSince
Director/Board Member 62 31/12/12
Director/Board Member 65 27/02/20
Chairman 68 31/12/12
More insiders
Date Price Change Volume
12/04/24 86.1 +0.55% 2,419,969
11/04/24 85.63 -0.58% 2,226,966
10/04/24 86.13 -0.28% 2,274,261
09/04/24 86.37 +0.02% 2,229,515
08/04/24 86.35 +0.34% 2,514,209

Delayed Quote Swiss Exchange, April 12, 2024 at 04:31 pm

More quotes
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
94.45 USD
Average target price
107.9 USD
Spread / Average Target
+14.25%
Consensus